TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES
\nBled, Slovenia, May 28-30, 2017<\/strong><\/p>\n

Agenda (preliminary)<\/strong>
\nSunday, 28 May<\/strong><\/p>\n\n\n\n\n\n\n

13.00-19.00<\/td>\n	REGISTRATION \u2013 Welcome desk (Foyer)<\/td>\n<\/tr>\n
13.00-19.00<\/td>\n	EXHIBITION SET UP (Foyer)<\/td>\n<\/tr>\n
13.00-16.00<\/td>\n	ICADTS Executive Board meeting (Libertas room)<\/td>\n<\/tr>\n
14.00-22.00<\/td>\n	PRE-CONFERENCE VISITS AND WELCOME RECEPTION (at 19.00, Bled Castle)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n  <\/p>\n Monday, 29 May<\/strong><\/p>\n\n\n\n\n\n\n\n\n \u00a008.00-19.00<\/td>\n REGISTRATION \u2013 Welcome desk (Foyer)<\/td>\n<\/tr>\n \u00a008.00-18.00<\/td>\n EXHIBITION (Foyer)<\/td>\n<\/tr>\n \u00a009.00-09.30<\/td>\n WELCOME<\/strong> (Jupiter room)<\/strong><\/p>\n Introduction:<\/strong> Majda Zorec Karlov\u0161ek<\/strong>, President, Association FORTOX<\/p>\n Welcome messages: <\/strong><\/p>\n Janez Fajfar<\/strong>, Mayor, Municipality of Bled<\/p>\n Kathryn Stewart<\/strong>, President, International Council on Alcohol, Drugs and Traffic Safety<\/p>\n Prof. Santo Davide Ferrara<\/strong>, President, International Academy of Legal Medicine<\/p>\n Vesna Marinko<\/strong>, Slovenian Traffic Safety Agency<\/p>\n Vesna Kerstin Petri\u010d<\/strong>, Ministry for Health, Slovenia<\/p>\n Robert Vehovar<\/strong>, Republic of Slovenia, Ministry of the Interior, Police, General Police Directorate<\/p>\n Robert \u0160taba<\/strong>, Vicepresident, FEVR (European Federation of Road Traffic Victims |\u00a0F\u00e9d\u00e9ration Europ\u00e9enne des Victimes de la Route), and President of Safe Journey Institute (Zavod Varna pot)<\/p>\n David Razbor\u0161ek<\/strong>, Director, VOZIM Institute (Zavod Vozim), Leader of the project \u201cI still drive \u2013 but I cannot walk\u201d\u00a0 (\u0160e vedno vozim-vendar ne hodim)<\/td>\n<\/tr>\n \u00a009.30-10.40<\/td>\n SESSION 1 \u2013 TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES<\/strong><\/p>\n Chair:\u00a0 <\/strong>Kathryn Stewart, Majda Zorec Karlov\u0161ek<\/strong><\/p>\n \u00a0<\/em><\/strong><\/p>\n Taking action in impaired driving worldwide:\u00a0 Where we have been, where we are going, and the role of ICADTS<\/strong><\/p>\n Kathryn Stewart<\/em><\/p>\n ICADTS, Prevention Research Center, USA<\/p>\n A Paradigm Shift to a Safe System; Lessons from the Netherlands<\/strong><\/p>\n Wendy Weijermars <\/em><\/p>\n SWOV, Netherlands<\/p>\n  <\/p>\n Improving Road Safety in the Western Balkan (\u201cWB6\u201d) countries \u2013 Connectivity Agenda\u00a0<\/strong><\/p>\n Liljana \u00c7ela\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em> \n<\/strong>South East Europe Transport Observatory (SEETO), Republic of Serbia<\/p>\n  <\/p>\n Effective measures to reduce alcohol \u2013 related harm: Alcohol policy in Slovenia.<\/strong><\/p>\n Vesna Kerstin Petri\u010d, Nata\u0161a Bla\u017eko,<\/u><\/em><\/p>\n Ministry for Health, Slovenia<\/em><\/td>\n<\/tr>\n 10.40-11.00<\/td>\n Break<\/td>\n<\/tr>\n 11.00-12.30<\/td>\n SESSION 1 \u2013 TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES<\/strong><\/p>\n Chair: Evelyn Vingilis<\/strong><\/p>\n  <\/p>\n Tech, Policy and Research Innovations that Launched the Interlock Age<\/strong><\/p>\n Paul Marques <\/em><\/p>\n PIRE, USA<\/p>\n  <\/p>\n\n\n\n\n Drink and driving \u2013 why we so often fail to learn from best practice and experience<\/strong><\/td>\n<\/tr>\n Matej Ko\u0161ir<\/u><\/em> and Sanela Tali\u0107<\/em><\/p>\n\n\n\n\n\n\n\n Institute for Research and Development “Utrip”, Slovenia<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \u00a0<\/strong><\/p>\n Alcohol and driving:\u00a0 Numbers, trends, attitudes, and new technologies<\/strong><\/p>\n Majda Zorec Karlovsek <\/em><\/p>\n Association FORTOX, Ljubljana, Slovenia<\/p>\n  <\/p>\n Alcohol interlocks and drink driving rehabilitation in the European Union<\/strong><\/p>\n Sjoerd Houwing <\/em><\/p>\n SWOV, The Hague, Netherlands<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n 12.30-13.30<\/td>\n Lunch<\/td>\n<\/tr>\n 13.30-15.00<\/td>\n How to start interlock programmes?<\/strong><\/p>\n Chair: <\/strong>Sjoerd Houwing,\u00a0Paul Marques <\/em><\/p>\n WORKSHOP \u2013 based on \u00bbBest practice and guidelines for EU Member States <\/strong><\/td>\n<\/tr>\n 15.00-15.15<\/td>\n Break<\/td>\n<\/tr>\n 15.15-16.15<\/td>\n \n\n\n\n \u00a0<\/strong>SESSION 2<\/strong> \u2013 ALCOHOL, DRUGS AND DRIVING – \u00a0EPIDEMIOLOGICAL RESEARCH<\/strong><\/p>\n Chair: Gordon Smith<\/strong><\/p>\n  <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n S<\/strong>urvey of alcohol and drug use among drivers in the Arctic county of Finnmark (Norway)<\/strong><\/td>\n<\/tr>\n Ragnhild Elen Gjulem Jamt<\/u><\/em>, Hallvard Gjerde, Stig Tore Bogstrand<\/em><\/td>\n<\/tr>\n <\/td>\n<\/tr>\n Department of Forensic Sciences, Oslo University Hospital, Oslo, Norway<\/td>\n<\/tr>\n P<\/strong>sychoactive drugs prescription in DUIA population: An emerging public health and traffic safety concern<\/strong><\/p>\n Elettra Carini<\/u><\/em>, Carmela Centola, Manuel Papi, Adriano Tagliabracci, Raffaele Giorgetti <\/em><\/p>\n Section of Legal Medicine, Universit\u00e0 Politecnica delle Marche, Ancona, Italy<\/td>\n<\/tr>\n Prevalence of drug and polydrug abuse in drunk drivers. Possible implications in the driving license regranting system<\/strong><\/td>\n<\/tr>\n Snenghi R1<\/sup>, Pelletti G1<\/sup>,<\/u> Frigo AC2<\/sup>, Nalesso A1<\/sup>, Favretto D1<\/sup>, Montisci M1<\/sup>, Ferrara SD1<\/sup><\/em><\/td>\n<\/tr>\n <\/td>\n<\/tr>\n 1<\/sup>Legal Medicine and Toxicology, University-Hospital of Padova, Italy;<\/p>\n 2<\/sup>Biostatistics, Epidemiology and Public Health Unit, University of Padova, Italy<\/td>\n<\/tr>\n Forensic Toxicology Unit- Experimental Medicine Department University of Campania \u201cL. Vanvitelli\u201d, Italy<\/p>\n  <\/p>\n\n\n\n\n\n\n\n\n\n Incidence of alcohol and drugs use among drivers injured in road accidents in Campania (Italy) during 2009-2016 years.<\/strong><\/td>\n<\/tr>\n Anna Carfora<\/u>, Paola Cassandro, Anna Cucciardi, Luisa Russello, Raffaella Petrella, Renata Borriello<\/td>\n<\/tr>\n <\/td>\n<\/tr>\n Forensic Toxicology Unit- Experimental Medicine Department University of Campania \u201cL. Vanvitelli\u00ab, Italy<\/p>\n  <\/p>\n Incidence of alcohol and drug use among pedestrians and cyclists fatally injured in road accidents in Slovenia<\/strong><\/p>\n Ticijana Prijon1<\/sup>, Toma\u017e \u010cak\u01611<\/sup><\/u>, Branko Ermenc2<\/sup><\/em><\/p>\n 1<\/sup>Health Insurance Institute of Slovenia<\/p>\n 2<\/sup>Institute of Forensic\u00a0 medicine, Medical Faculty, University of Ljubljana Slovenia<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n  <\/p>\n  <\/td>\n<\/tr>\n <\/td>\n <\/td>\n <\/td>\n <\/td>\n <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n 16.15-16.30<\/td>\n Break<\/td>\n<\/tr>\n 16.30-18.00<\/td>\n \n\n\n\n SESSION 3:\u00a0 DETECTION OF PSYCHOACTIVE DRUGS<\/strong><\/p>\n Chair: Jeremy Davey , Kerry Armstrong<\/strong><\/p>\n Australian roadside drug testing: Moving to a next generational response<\/strong><\/p>\n Jeremy Davey<\/u> and\u00a0 Kerry Armstrong<\/p>\n Centre for Accident Research and Road Safety- Queensland University of Technology, Australia<\/p>\n\n\n\n\n \u00a0<\/strong><\/p>\n Can the use of Dr\u00e4ger DrugTest 5000 correctly identify drug drivers? Evaluation in a naturalistic setting in Norway<\/strong><\/td>\n<\/tr>\n Hallvard Gjerde1<\/sup><\/u><\/em>, H\u00e5vard Furuhaugen1<\/sup>, Grethe Brennhovd Clausen2<\/sup><\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n 1<\/sup>Department of Forensic Sciences, Oslo University Hospital, Norway;<\/p>\n 2<\/sup>Norwegian Mobile Police Service, Stavern, Norway<\/p>\n \u00a0<\/strong><\/p>\n Evaluation of some abuse drugs in Patients of an Emergency Hospital<\/strong><\/p>\n R.A.Adeldayem; R.A.Mandour<\/u><\/em><\/p>\n Toxicology Unit, Emergency Hospital, Mansoura University, Egypt<\/p>\n \u00a0<\/strong><\/p>\n Technique of receiving antibodies to synthetic cannabinoids \u00abspices\u00bb and some antidepressants for development of diagnostic test system<\/strong><\/p>\n Fazliddin Jalilov1<\/sup>, Lola Pulatova2<\/sup>, Shohista Tashmukhamedov3<\/sup><\/em><\/p>\n 1<\/sup>Tashkent Pharmaceutical Institute, Tashkent ,Uzbekistan<\/p>\n 2<\/sup>Higher military customs institute, Tashkent, Uzbekistan<\/p>\n 3<\/sup>National University of Uzbekistan, Tashkent, Uzbekistan<\/p>\n \u00a0<\/em><\/p>\n\n\n\n\n\n\n Application of the Thermodesorption surface \u2013 ionization spectroscopy method in Amitriptyline analysis<\/strong><\/td>\n<\/tr>\n Fazliddin Jalilov1<\/sup><\/u><\/em>, Mansur Tojiev1<\/sup>, Lola Pulatova2<\/sup>, Feruza Jalilova1<\/sup> <\/em><\/td>\n<\/tr>\n <\/td>\n<\/tr>\n 1<\/sup>Tashkent Pharmaceutical Institute, Tashkent,Uzbekistan<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n 2<\/sup>Higher military customs institute, Tashkent, Uzbekistan<\/p>\n \u00a0<\/strong><\/p>\n \u00a0<\/em><\/strong><\/p>\n Break 5 min<\/em><\/strong><\/p>\n \u00a0<\/strong><\/p>\n \u00a0<\/strong><\/p>\n SESSION 4: TRAFFIC SAFETY: EDUCATION<\/strong><\/p>\n Chair: Mary Sheehan<\/strong><\/p>\n  <\/p>\n Risky Driving Videos on YouTube:\u00a0 Should We Be Concerned about this Social Medium?<\/strong><\/p>\n Evelyn Vingilis1<\/sup><\/u><\/em>, Larissa Vingilis-Jaremko2<\/sup>, Z\u00fcmr\u00fct Y\u0131ld\u0131r\u0131m-Yenier1<\/sup>, Christine Wickens3<\/sup>, Jane Seeley<\/em>1<\/sup><\/em>, Judy Fleiter<\/em>4<\/sup><\/em>, Daniel H. Grushka<\/em>1<\/sup><\/em><\/p>\n 1<\/sup>Department of Family Medicine, University of Western Ontario, London, Canada, N6A 5C1.<\/p>\n 2<\/sup>Department of Psychology, York University, 4700 Keele St., Toronto, Canada M3J 1P3<\/p>\n 3<\/sup>Social and Epidemiological Research, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Canada M5S 2S1<\/p>\n 4<\/sup>Centre for Accident Research and Road Safety-Queensland, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia<\/p>\n \u00a0<\/em><\/p>\n  <\/p>\n\n\n\n\n\n\n\n Street Racing Videos and their Popularity – A YouTube Content Analysis<\/strong><\/td>\n<\/tr>\n Jane<\/span> Seeley<\/span>1<\/sup>, <\/em>Christine Wickens3<\/sup>, <\/em>Larissa Vingilis-Jaremko2<\/sup>, <\/em>Judy Fleiter4<\/sup>, <\/em>Z\u00fcmr\u00fct Yildirim-Yenier1<\/sup>, <\/em>Daniel Grushka1<\/sup>, <\/em>Evelyn Vingilis1<\/sup><\/em><\/td>\n<\/tr>\n <\/td>\n<\/tr>\n 1<\/sup>Department of Family Medicine, University of Western Ontario, London, Canada, N6A 5C1.<\/p>\n 2<\/sup>Department of Psychology, York University, 4700 Keele St., Toronto, Canada M3J 1P3<\/p>\n 3<\/sup>Social and Epidemiological Research, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Canada M5S 2S1<\/p>\n 4<\/sup>Centre for Accident Research and Road Safety-Queensland, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia<\/p>\n \u00a0<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n 19.00-22.00<\/td>\n GALA DINNER<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n  <\/p>\n Tuesday, 30 May<\/strong><\/p>\n\n\n\n\n\n \u00a008.00-15.00<\/td>\n REGISTRATION \u2013 Welcome desk (Foyer)<\/td>\n<\/tr>\n \u00a008.00-15.00<\/td>\n EXHIBITION (Foyer)<\/td>\n<\/tr>\n 8.30-10.40<\/td>\n \n\n\n\n SESSION 5 \u2013 NON-ALCOHOL DRUGS AND DRIVING<\/strong><\/p>\n Chair:Jan Ramaekers<\/strong><\/p>\n Drugs and driving: Trends and challenges<\/strong><\/p>\n Richard Compton,<\/em><\/p>\n National Highway Traffic Safety Administration, USA<\/p>\n \u00a0<\/em><\/strong><\/p>\n SESSION 6 – \u00a0MEDICINAL DRUGS: RECREATIONAL, THERAPEUTIC AND LONG-TERM THERAPEUTIC USE<\/strong><\/p>\n Chair:Jan Ramaekers<\/strong><\/p>\n Introduction and background of a Dutch collaboration to assess long term effects of medicinal drugs (classified ICADTS class III) on driver performance<\/strong><\/p>\n Joris C Verster1,2,3<\/sup><\/u><\/em>, Aurora J.A.E. van de Loo1,2<\/sup>, Nick N.J.J.M. van der Sluiszen4<\/sup>, Annemiek Vermeeren4<\/sup>, Karel A. Brookhuis5<\/sup>, Janet Veldstra5<\/sup>, Joke H. van Dijken5<\/sup>, Johannes G. Ramaekers4<\/sup><\/em><\/p>\n \u00a0<\/em><\/p>\n 1 <\/sup>Division Pharmacology, Utrecht University, Utrecht, The Netherlands;<\/p>\n 2 <\/sup>Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands;<\/p>\n 3 <\/sup>Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia;<\/p>\n 4 <\/sup>Faculty of Psychology and Neuroscience, Division Psychopharmacology, Maastricht University, The Netherlands;<\/p>\n 5<\/sup> Faculty of Behavioural and Social sciences, Division Psychology, University of Groningen, The Netherlands<\/p>\n  <\/p>\n Long-term effects of antidepressant and benzodiazepine usage on actual driving and neurocognitive performance<\/strong><\/p>\n Nick N.J.J.M. van der Sluiszen<\/u><\/em>1<\/sup><\/em>, Annemiek Vermeeren1<\/sup>, Joris C. Verster2<\/sup>, Aurora J.A.E. van de Loo2<\/sup>, Karel A. Brookhuis3<\/sup>, Janet Veldstra3<\/sup> , Joke H. van Dijken3 <\/sup>and Johannes G. Ramaekers1<\/sup><\/em><\/p>\n \u00a0<\/em><\/p>\n 1 <\/sup>Faculty of Psychology and Neuroscience, Division Psychopharmacology, Maastricht University, The Netherlands;<\/p>\n 2 <\/sup>Faculty of Pharmaceutical Sciences, Division Pharmacology, University Utrecht, The Netherlands<\/p>\n 3 Faculty of Behavioural and Social sciences, Division Psychology, University of Groningen, The Netherlands<\/p>\n \u00a0<\/strong><\/p>\n Long term effects of antidepressants and benzodiazepines on simulated driving performance.<\/strong><\/p>\n \u00a0<\/em><\/p>\n J.H. van Dijken,<\/u><\/em> J.L. Veldstra, K.A. Brookhuis, D. de Waard<\/em><\/p>\n University of Groningen, the Netherlands<\/p>\n  <\/p>\n\n\n\n\n\n\n\n\n Polypharmacy of ICADTS III drugs and long-term effects on driving<\/strong><\/td>\n<\/tr>\n Vinckenbosch F<\/u><\/em>, van der Sluiszen N, Veldstra J, van Dijken J, Verster JC, van de Loo A, Vermeeren A, Brookhuis K, Ramaekers JG<\/em><\/td>\n<\/tr>\n <\/td>\n<\/tr>\n Maastricht University, The Netherlands<\/p>\n \u00a0<\/em><\/p>\n BREAK 5 min<\/u><\/em><\/td>\n<\/tr>\n Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients<\/strong><\/td>\n<\/tr>\n Schumacher, M. B., Jongen, S.,<\/u> Knoche, A., Petzke, F., Vuurman, E. F., Vollrath, M., & Ramaekers J.G.<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n University Maastricht, Federal Highway Research Institute, Universitaetsmedizin Goettingen, Technische Universitaet Braunschweig<\/p>\n \u00a0<\/em><\/p>\n\n\n\n\n\n\n\n\n Therapeutic and recreational use of Codeine, Tramadol, Zolpidem and Ketamine in drivers<\/strong><\/td>\n<\/tr>\n Favretto Donata, Visentin Sindi<\/u>, Bennici Silvia Eugenia, Vogliardi Susanna, Stocchero Giulia, Montisci Massimo, Snenghi Rossella, Ferrara Santo Davide<\/em><\/td>\n<\/tr>\n <\/td>\n<\/tr>\n Legal Medicine and Toxicology, Department of Cardiological, Thoracic and Vascular Sciences, School of Medicine, University Hospital of Padova, Padova, Italy.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \u00a0<\/em><\/strong><\/p>\n  <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n 10.40-11.00<\/td>\n Break<\/td>\n<\/tr>\n 11.00-13.10<\/td>\n \n\n\n\n \u00a0<\/strong><\/p>\n SESSION 7<\/strong> \u2013 CANNABIS AND DRIVING<\/strong><\/p>\n \u00a0<\/em><\/strong><\/p>\n\n\n\n \n\n\n\n\n\n Cannabis and tolerance: acute drug impairment as a function of cannabis use history.<\/strong><\/td>\n<\/tr>\n Ramaekers Jan<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n Faculty of Psychology and Neuroscience, Division Psychopharmacology, Maastricht University, The Netherlands<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Determination of legislative limits for tetrahydrocannabinol in Norway<\/strong><\/p>\n Vigdis Vindenes<\/em><\/p>\n Oslo University Hospital, Section of Drug Abuse Research, Norway<\/em><\/p>\n  <\/p>\n\n\n\n\n\n\n The Journey To Legalize Cannabis in Canada<\/strong><\/td>\n<\/tr>\n Danielle Y.R. Comeau;<\/u><\/em> Felix J.E. Comeau; Denise Connerty<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Alcohol Countermeasure Systems Corp., Toronto, Canada<\/p>\n \u00a0<\/em><\/p>\n Relationship between medical cannabis, alcohol use and traffic accidents \n<\/strong>Du\u0161an Nolimal1,2<\/sup><\/em><\/p>\n 1<\/sup>NIJZ – National institute for Public Health,Ljubljana<\/p>\n 2<\/sup>ICANNA – International Institute for Cannabinoids, Ljubljana<\/p>\n \u00a0<\/em><\/p>\n \u00a0<\/em><\/p>\n Epidemiological studies on risk for crash involvement after cannabis use<\/strong><\/p>\n Hallvard Gjerde1<\/sup><\/u><\/em> and J\u00f8rg M\u00f8rland2<\/sup><\/em><\/p>\n 1<\/sup>Department of Forensic Sciences, Oslo University Hospital, Norway;<\/p>\n 2<\/sup>Norwegian Institute of Public Health, Oslo, Norway<\/p>\n \u00a0<\/strong><\/p>\n \u00a0<\/strong><\/p>\n Discussion<\/strong><\/p>\n \u00a0<\/strong><\/p>\n Closing remarks:\u00a0Kathryn Stewart<\/strong><\/p>\n  <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n 13.10-14.10<\/td>\n Lunch<\/td>\n<\/tr>\n <\/td>\n <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n  <\/p>\n Wednesday, 31 May<\/strong><\/p>\n\n\n\n 8.00-22.00<\/td>\n Post-conference visit (Sevnica)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n  <\/p>\n  <\/p>\n  <\/p>\n  <\/p>\n","protected":false},"excerpt":{"rendered":" TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES Bled, Slovenia, May 28-30, 2017 Agenda (preliminary) Sunday, 28 May 13.00-19.00 REGISTRATION \u2013 Welcome desk (Foyer) 13.00-19.00 EXHIBITION SET UP (Foyer) 13.00-16.00 ICADTS Executive Board meeting (Libertas room) 14.00-22.00 PRE-CONFERENCE VISITS AND WELCOME RECEPTION (at 19.00, Bled Castle)   Monday, 29 May \u00a008.00-19.00 REGISTRATION \u2013 Welcome desk […]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":66,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/pages\/68"}],"collection":[{"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/comments?post=68"}],"version-history":[{"count":15,"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/pages\/68\/revisions"}],"predecessor-version":[{"id":383,"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/pages\/68\/revisions\/383"}],"up":[{"embeddable":true,"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/pages\/66"}],"wp:attachment":[{"href":"https:\/\/www.fortox.si\/fortox-2017\/wp-json\/wp\/v2\/media?parent=68"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}